Peng Wei

Vice President at Besunyen Holdings Co. Ltd.

Peng Wei

Peng Wei

Vice President at Besunyen Holdings Co. Ltd.

Biography

Ms. PENG Wei is our Vice President principally in charge of our research and development, production and operation of medicines. Ms. Peng is also a director and the legal representative of some subsidiaries of our Group. Ms. Peng joined our Group in October 2017 and has more than 30 years of experience in the pharmaceutical industry. Between 1995 and October 2012, she held various senior positions in The United Laboratories International Holdings Limited (a company listed on the Stock Exchange, stock code: 3933), including vice chairman, executive director and general manager. Ms. Peng founded Zhongshan Wanhan and Wanyuan, which were acquired by our Group in October 2017. She graduated from the Department of Medicine of Xi’an Medical University in 1983 and obtained an Executive MBA degree from Lingnan College of Sun Yat-Sen University in 2006.

Overview
RelSci Relationships

44

Number of Boards

1

Birthday

1963

Age

57

Relationships
RelSci Relationships are individuals Peng Wei likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Vice President at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Vice President, Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Executive Director & Vice President at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Former Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Non-Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Professor at The University of Hong Kong (HKU)

Relationship likelihood: Strong

Independent Non-Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Director, Production Factory at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Paths to Peng Wei
Potential Connections via
Relationship Science
You
Peng Wei
Vice President at Besunyen Holdings Co. Ltd.
Education
Undergraduate Degree
Class of 1983

Xian Jiaotong University is a school.

Career History
Vice President
Current

Besunyen Holdings Co. Ltd. is an investment company, which engages in the manufacture and sale of therapeutic tea products. It operates through the following segments: Tea Products, and Slimming and Other Medicine. The Tea Products segment offers detox tea, slimming tea, and other tea products. The Slimming and Other Medicine segment provides slimming and other medicine. The company was founded by Yi Hong Zhao and Yan Gao on August 5, 2009 and is headquartered in Hong Kong.

Vice Chairman & General Manager
2010 - 2012

United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA. The Bulk Medicine segment includes amoxicillin and insulin. The Finished Products segment includes the sale of antibiotics and non-antibiotics finished products, and capsule casings including Semi-synthetic penicillins antibiotics, Cephalosporins antibiotics, and Insulin products. The company was founded on March 6, 2006 and is headquartered in Hong Kong.

Boards & Committees
Member, Board of Directors
2010 - 2012

United Laboratories International Holdings Ltd. is an investment company, which engages in the research, development, production and operation of medical intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical preparations. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The company was founded on March 6, 2006 and is headquartered in Hong Kong.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Peng Wei. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Peng Wei's profile does not indicate a business or promotional relationship of any kind between RelSci and Peng Wei.